9 studies found for:    appendiceal cancer | Open Studies
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Recruiting Crossover Trial of Systemic Chemotherapy in Patients With Metastatic Well-differentiated Mucinous Appendiceal Adenocarcinomas With Pseudomyxoma Peritonea
Condition: Gastrointestinal Neoplasms
Intervention: Behavioral: Questionnaire
2 Recruiting ICARuS Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal Metastasis
Conditions: Appendix Cancer;   Colorectal Cancer
Interventions: Procedure: Cytoreductive Surgery;   Drug: HIPEC with Mitomycin-C;   Drug: EPIC with FUDR and Leucovorin
3 Recruiting Antibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal Origin
Conditions: Pseudomyxoma Peritonei;   Appendiceal Neoplasms
Intervention: Drug: PrevPac (Prevacid, Amoxicillin, Clarithromycin)
4 Recruiting Surgery and Oxaliplatin or Mitomycin C in Treating Patients With Tumors of the Appendix
Conditions: Carcinoma of the Appendix;   Primary Peritoneal Cavity Cancer
Interventions: Drug: mitomycin C;   Drug: oxaliplatin;   Procedure: therapeutic conventional surgery;   Other: quality-of-life assessment;   Drug: hyperthermic intraperitoneal chemotherapy
5 Not yet recruiting Postoperative Chemotherapy in High-Grade Appendiceal Adenocarcinoma With Peritoneal Carcinomatosis
Condition: Cancer
Intervention: Drug: systemic chemotherapy
6 Recruiting Biweekly Intraperitoneal Oxaliplatin With Systemic Capecitabine and Bevacizumab for Patients With Peritoneal Carcinomatosis From Appendiceal or Colorectal Cancer
Condition: Carcinoma
Interventions: Drug: Intraperitoneal Oxaliplatin;   Drug: Bevacizumab;   Drug: Capecitabine
7 Recruiting Phase I/IIA Study MK-3475 With Chemotherapy in Patients With Advanced GI Cancers
Condition: Advanced GI Cancer
Intervention: Drug: MK-3475
8 Recruiting Cytoreduction Followed by Normothermic Versus Hyperthermic Intraperitoneal Intraoperative Chemoperfusion (HIPEC): a Study in Peritoneal Carcinomatosis
Condition: Peritoneal Carcinomatosis
Interventions: Procedure: Hyperthermic intraoperative Peritoneal Chemoperfusion;   Drug: Hyperthermic intraoperative Peritoneal Chemoperfusion
9 Unknown  Optimizing Influenza Vaccination in Surgical Oncology Patients
Condition: Influenza
Intervention: Biological: Influenza vaccine

Indicates status has not been verified in more than two years